Randomized Study of Intravenous Calaspargase Pegol (SC-PEG Asparaginase) and Intravenous Oncaspar in Children and Adolescents With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Calaspargase pegol (Primary) ; Pegaspargase
- Indications Acute lymphoblastic leukaemia; Lymphoma
- Focus Adverse reactions; Pharmacokinetics
- 25 Sep 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2020.
- 25 Sep 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2018.
- 09 Jun 2017 Planned End Date changed from 1 Jun 2017 to 1 Jul 2017.